Spotlight Therapeutics, a Bay Area biotech company that raised $66 million from investors, including GV, has shut down.
BridgeBio's launch of Attruby in the U.S. is off to a strong start. Read how this successful effort puts the biotech in a ...
Get to know honoree Lake Paul, founder and CEO of BioAnalysis. Lake Paul founder and CEO, BioAnalysis Last year, BioAnalysis marked a major milestone. The Philadelphia non-clinical contract research ...
Challenging powerhouse Pfizer, BridgeBio's launch of Attruby is off to a 'great start,' analyst says
An intriguing battle is brewing in the market to treat patients with transthyretin amyloid cardiomyopathy (ATTR-CM). | BridgeBio reported that 1,028 unique prescriptions have been written by 516 ...
The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and ...
An unorthodox putting technique called AimPoint is taking over the sport. Not everyone is happy about it.
In the past week, a Boston biotech led by longtime industry CEO Harvey Berger said it plans to shut down, while another ...
Zealand Pharma achieved notable organizational growth in 2024 with a 30% increase in the number of employees compared to 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback